Literature DB >> 1705999

The threshold of pain and neurotransmitter's change on pain in Parkinson's disease.

K Urakami1, K Takahashi, E Matsushima, K Sano, S Nishikawa, T Takao.   

Abstract

Among Parkinson's disease (PD) patients complaining of pain, 10 with pain not associated with a motor fluctuation or L-dopa therapy were evaluated. The controls were 14 PD without pain and eight with thalamic pain syndrome. The threshold of pain and neurotransmitters in CSF were measured in the three groups. In PD with pain, the maximum tolerance level and tourniquet pain ratio decreased significantly. In PD with pain, the score on the self-depression scale increased significantly and 5-hydroxy-indole acetic acid (5-HIAA) among the neurotransmitters decreased significantly. These results suggest that decreases in the threshold of pain and changes of serotonin in CSF are involved in the development of specific pain in PD who do not respond to L-dopa.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1705999     DOI: 10.1111/j.1440-1819.1990.tb01634.x

Source DB:  PubMed          Journal:  Jpn J Psychiatry Neurol        ISSN: 0912-2036


  6 in total

1.  Pain and motor complications in Parkinson's disease.

Authors:  M Tinazzi; C Del Vesco; E Fincati; S Ottaviani; N Smania; G Moretto; A Fiaschi; D Martino; G Defazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

2.  The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine Production.

Authors:  Jillienne C Touchette; Joshua W Little; Gerald H Wilken; Daniela Salvemini; Heather Macarthur
Journal:  Neuroscience       Date:  2018-02-05       Impact factor: 3.590

3.  Pain in multiple system atrophy.

Authors:  F Tison; G K Wenning; M A Volonte; W R Poewe; P Henry; N P Quinn
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

4.  Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study.

Authors:  A Gerdelat-Mas; M Simonetta-Moreau; C Thalamas; F Ory-Magne; T Slaoui; O Rascol; C Brefel-Courbon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-15       Impact factor: 10.154

Review 5.  Towards optimising experimental quantification of persistent pain in Parkinson's disease using psychophysical testing.

Authors:  Rory V Smith; Patrick Wilkins; Kirsty Bannister; Tatum M Cummins
Journal:  NPJ Parkinsons Dis       Date:  2021-03-17

6.  Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study.

Authors:  Christine Petschow; Lukas Scheef; Sebastian Paus; Nadine Zimmermann; Hans H Schild; Thomas Klockgether; Henning Boecker
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.